Finke Daniel P
Insider
First SEC filing: May 18, 2026 · Latest: May 18, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 1, 2023 | CVS | F | 3,856 | $74.31 | $286,539 | 35,068 Direct | -9.91% | Disposed | 17.1% (price as of 2026-10-05) |
| April 1, 2023 | CVS | A | 74,228 | $74.31 | $5,515,883 | 74,228 Direct | · | Acquired | 17.1% (price as of 2026-10-05) |
| Aug. 3, 2022 | CVS | M | 9,546 | · | · | 19,094 Direct | -33.33% | Disposed | (price as of 2026-10-05) |
| Aug. 3, 2022 | CVS | S 10b5-1 | 9,546 | $100.00 | $954,600 | 32,150 Direct | -22.89% | Disposed | -13.0% (price as of 2026-10-05) |
| Aug. 3, 2022 | CVS | M | 9,546 | $52.37 | $499,924 | 41,696 Direct | +29.69% | Acquired | 66.1% (price as of 2026-10-05) |
| April 5, 2022 | CVS | S 10b5-1 | 5,941 | $100.00 | $594,100 | 32,150 Direct | -15.60% | Disposed | -13.0% (price as of 2026-10-05) |
| April 4, 2022 | CVS | M | 27,166 | · | · | 27,166 Direct | -50.00% | Disposed | (price as of 2026-10-05) |
| April 4, 2022 | CVS | M | 16,161 | · | · | 16,161 Direct | -50.00% | Disposed | (price as of 2026-10-05) |
| April 4, 2022 | CVS | S 10b5-1 | 12,032 | $100.13 | $1,204,764 | 38,091 Direct | -24.00% | Disposed | -13.1% (price as of 2026-10-05) |
| April 4, 2022 | CVS | S 10b5-1 | 27,166 | $100.13 | $2,720,132 | 50,123 Direct | -35.15% | Disposed | -13.1% (price as of 2026-10-05) |
| April 4, 2022 | CVS | M | 27,166 | $58.34 | $1,584,864 | 77,289 Direct | +54.20% | Acquired | 49.1% (price as of 2026-10-05) |
| April 4, 2022 | CVS | S 10b5-1 | 16,161 | $100.13 | $1,618,201 | 50,123 Direct | -24.38% | Disposed | -13.1% (price as of 2026-10-05) |
| April 4, 2022 | CVS | M | 16,161 | $54.19 | $875,765 | 66,284 Direct | +32.24% | Acquired | 60.6% (price as of 2026-10-05) |
| April 1, 2022 | CVS | F | 13,532 | $101.09 | $1,367,950 | 44,182 Direct | -23.45% | Disposed | -13.9% (price as of 2026-10-05) |
| April 1, 2022 | CVS | F | 3,856 | $101.09 | $389,803 | 50,123 Direct | -7.14% | Disposed | -13.9% (price as of 2026-10-05) |
| April 1, 2022 | CVS | A | 51,975 | $101.09 | $5,254,153 | 51,975 Direct | · | Acquired | -13.9% (price as of 2026-10-05) |
| Feb. 21, 2022 | CVS | A | 34,387 | · | · | 57,714 Direct | +147.41% | Acquired | (price as of 2026-10-05) |
| June 7, 2021 | CVS | M | 32,320 | · | · | 32,322 Direct | -50.00% | Disposed | (price as of 2026-10-05) |
| June 7, 2021 | CVS | S 10b5-1 | 37,594 | $86.60 | $3,255,640 | 23,310 Direct | -61.73% | Disposed | 0.5% (price as of 2026-10-05) |
| June 7, 2021 | CVS | M | 32,320 | $54.19 | $1,751,421 | 60,904 Direct | +113.07% | Acquired | 60.6% (price as of 2026-10-05) |
| April 1, 2021 | CVS | A | 82,066 | $74.30 | $6,097,504 | 82,066 Direct | · | Acquired | 17.1% (price as of 2026-10-05) |
| April 1, 2021 | CVS | F | 4,540 | $74.30 | $337,322 | 28,565 Direct | -13.71% | Disposed | 17.1% (price as of 2026-10-05) |
| April 1, 2021 | CVS | F | 6,044 | $74.30 | $449,069 | 23,309 Direct | -20.59% | Disposed | 17.1% (price as of 2026-10-05) |
| March 2, 2021 | CVS | F | 2,413 | $68.94 | $166,352 | 15,073 Direct | -13.80% | Disposed | 26.2% (price as of 2026-10-05) |
| Feb. 1, 2021 | CVS | A | 14,280 | · | · | 24,079 Direct | +145.73% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2023 | CVS | Stock Option | Common Stock | $74.31 | April 1, 2033 | 74,228 | Acquired |
| Aug. 3, 2022 | CVS | Stock Option | Common Stock | $52.37 | May 31, 2029 | 9,546 | Disposed |
| April 4, 2022 | CVS | Stock Option | Common Stock | $58.34 | April 1, 2030 | 27,166 | Disposed |
| April 4, 2022 | CVS | Stock Option | Common Stock | $54.19 | April 1, 2029 | 16,161 | Disposed |
| April 1, 2022 | CVS | Stock Option | Common Stock | $101.09 | April 1, 2032 | 51,975 | Acquired |
| June 7, 2021 | CVS | Stock Option | Common Stock | $54.19 | April 1, 2029 | 32,320 | Disposed |
| April 1, 2021 | CVS | Stock Option | Common Stock | $74.30 | April 1, 2031 | 82,066 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 9 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 18, 2026 | CNC | Common Stock | · | Direct |
| Feb. 8, 2021 | CVS | Common Stock | 9,799 | Direct |
| Feb. 8, 2021 | CVS | Common Stock (restricted) | · | Direct |
| Feb. 8, 2021 | CVS | Common Stock (restricted) | · | Direct |
| Feb. 8, 2021 | CVS | Common Stock (restricted) | · | Direct |
| Feb. 8, 2021 | CVS | Common Stock (restricted) | · | Direct |
| Feb. 8, 2021 | CVS | Stock Option | 64,642 | Direct |
| Feb. 8, 2021 | CVS | Stock Option | 54,332 | Direct |
| Feb. 8, 2021 | CVS | Stock Option | 28,640 | Direct |